BioCopy will be partnering at Bio-Europe Spring, March 28-31, 2022.
We are showcasing our unique technology for vaccine development and immunotherapy.
With our BioCopy technology, we can measure thousands of molecular interactions on microarrays ultra-fast, label-free and simultaneously. Thus, we can identify the optimal candidates for selective and highly specific (safe) cancer therapeutics, e.g. (bispecific) TCRs/TCR mimetics.
Join us in the partnering section to learn more about our fast, efficient and tailor-made solutions.